What is your approach to systemic therapy in newly diagnosed colon cancer with synchronous solitary liver metastases?

This is an important and challenging clinical question. In general, I favor a neoadjuvant chemotherapy treatment approach for a variety of reasons. For one, the EORTC trial provides us with supportive data that perioperative FOLFOX is associated with a modest improvement in outcome compared to surge...